Across TCGA pan-cancer cohorts, ZNF736P1Y RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated ZNF736P1Y data layer.
The strongest signal is observed in testicular germ cell tumors (TGCT), where higher ZNF736P1Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF736P1Y expression acts as an unfavorable survival marker.
TGCT and BRCA are the cancer types where ZNF736P1Y RNA most reproducibly stratifies survival.